Found: 30
Select item for more details and to access through your institution.
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study.
- Published in:
- Hepatology Research, 2023, v. 53, n. 5, p. 409, doi. 10.1111/hepr.13876
- By:
- Publication type:
- Article
Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 249, doi. 10.1159/000514420
- By:
- Publication type:
- Article
Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma.
- Published in:
- Internal Medicine, 2022, v. 61, n. 21, p. 3157, doi. 10.2169/internalmedicine.9237-21
- By:
- Publication type:
- Article
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha‐fetoprotein after sorafenib in REACH and REACH‐2.
- Published in:
- Liver International, 2020, v. 40, n. 8, p. 2008, doi. 10.1111/liv.14462
- By:
- Publication type:
- Article
Effects of retinoids on the production of tumour necrosis factor-alpha and nitric oxide by lipopolysaccharide-stimulated rat Kupffer cells in vitro: evidence for participation of retinoid X receptor signalling pathway.
- Published in:
- Cell Biochemistry & Function, 1997, v. 15, n. 2, p. 95, doi. 10.1002/(SICI)1099-0844(19970601)15:2<95::AID-CBF727>3.0.CO;2-8
- By:
- Publication type:
- Article
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Dynamics of the neutrophil‑to‑lymphocyte ratio during lenvatinib treatment for unresectable hepatocellular carcinoma.
- Published in:
- Oncology Letters, 2024, v. 28, n. 1, p. N.PAG, doi. 10.3892/ol.2024.14442
- By:
- Publication type:
- Article
Tumor‑infiltrating CD8<sup>+</sup> T cells as a biomarker for chemotherapy efficacy in unresectable hepatocellular carcinoma.
- Published in:
- Oncology Letters, 2023, v. 25, n. 6, p. N.PAG, doi. 10.3892/ol.2023.13845
- By:
- Publication type:
- Article
Therapeutic efficacy of atezolizumab plus bevacizumab for hepatocellular carcinoma with WNT/β-catenin signal activation.
- Published in:
- Oncology Letters, 2022, v. 24, n. 1, p. N.PAG, doi. 10.3892/ol.2022.13337
- By:
- Publication type:
- Article
Hepatitis C virus eradication ameliorates the prognosis of advanced hepatocellular carcinoma treated with sorafenib.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 7, p. 543, doi. 10.1111/jvh.13681
- By:
- Publication type:
- Article
Serum α‐fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct‐acting antiviral treatment.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 1, p. 35, doi. 10.1111/jvh.13625
- By:
- Publication type:
- Article
Word Decoding of Protein Amino Acid Sequences with Availability Analysis: A Linguistic Approach.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0050039
- By:
- Publication type:
- Article
Risk factors for loss to follow‐up after the start of direct‐acting antiviral treatment for hepatitis C virus infection.
- Published in:
- JGH Open, 2023, v. 7, n. 2, p. 98, doi. 10.1002/jgh3.12855
- By:
- Publication type:
- Article
Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 195, doi. 10.1007/s40801-022-00348-w
- By:
- Publication type:
- Article
Kinetics of the hepatitis C virus during interferon therapy as a marker of therapeutic response.
- Published in:
- Journal of Gastroenterology & Hepatology, 2001, v. 16, n. 1, p. 29, doi. 10.1046/j.1440-1746.2001.02390.x
- By:
- Publication type:
- Article
Photosensitivity and Acute Liver Insufficiency in Late-Onset Erythropoietic Protoporphyria with a Chromosome 18q Abnormality.
- Published in:
- Case Reports in Dermatology, 2012, v. 4, n. 2, p. 144, doi. 10.1159/000341111
- By:
- Publication type:
- Article
All- trans retinoic acid suppresses liver injury induced by Propionibacterium acnes and lipopolysaccharide in rats.
- Published in:
- Journal of Gastroenterology & Hepatology, 1997, v. 12, n. 12, p. 887, doi. 10.1111/j.1440-1746.1997.tb00388.x
- By:
- Publication type:
- Article
CASE REPORT: Haemothorax due to hepatocellular carcinoma rupture successfully controlled by transcatheter arterial embolization.
- Published in:
- Journal of Gastroenterology & Hepatology, 1997, v. 12, n. 2, p. 156, doi. 10.1111/j.1440-1746.1997.tb00399.x
- By:
- Publication type:
- Article
Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4345, doi. 10.3390/cancers15174345
- By:
- Publication type:
- Article
Systemic Chemotherapy for Advanced Hepatocellular Carcinoma in Patients With Child-Pugh class B.
- Published in:
- Cancer Diagnosis & Prognosis, 2024, v. 4, n. 2, p. 111, doi. 10.21873/cdp.10295
- By:
- Publication type:
- Article
Neutrophil-to-Lymphocyte Ratio Predicts Immune-related Adverse Events in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
- Published in:
- Cancer Diagnosis & Prognosis, 2024, v. 4, n. 1, p. 34, doi. 10.21873/cdp.10282
- By:
- Publication type:
- Article
Combined Ultrasound and Computed Tomography Guidance in Radiofrequency Ablation for Hepatocellular Carcinoma Reduces Local Recurrence Rate.
- Published in:
- Cancer Diagnosis & Prognosis, 2023, v. 3, n. 6, p. 660, doi. 10.21873/cdp.10269
- By:
- Publication type:
- Article
An Imaging Feature Predicts Efficacy of Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancer Diagnosis & Prognosis, 2023, v. 3, n. 4, p. 468, doi. 10.21873/cdp.10241
- By:
- Publication type:
- Article
Similar Efficacy Between Atezolizumab Plus Bevacizumab Versus Hepatic Arterial Infusion Chemotherapy For Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Cohort Study.
- Published in:
- In Vivo, 2024, v. 38, n. 4, p. 1854, doi. 10.21873/invivo.13639
- By:
- Publication type:
- Article
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study.
- Published in:
- Journal of Gastroenterology, 2021, v. 56, n. 2, p. 181, doi. 10.1007/s00535-020-01753-0
- By:
- Publication type:
- Article
Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Therapeutic efficacy of lenvatinib for hepatocellular carcinoma with iso-high intensity in the hepatobiliary phase of Gd-EOB-DTPA-MRI.
- Published in:
- Molecular & Clinical Oncology, 2022, v. 16, n. 2, p. 1, doi. 10.3892/mco.2021.2486
- By:
- Publication type:
- Article
Diagnostic features of autoimmune hepatitis in SARS-CoV-2-vaccinated vs. unvaccinated individuals.
- Published in:
- Experimental & Therapeutic Medicine, 2024, v. 28, n. 3, p. 1, doi. 10.3892/etm.2024.12626
- By:
- Publication type:
- Article
FIB‑4 index and serum α‑fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy.
- Published in:
- Experimental & Therapeutic Medicine, 2023, v. 26, n. 3, p. N.PAG, doi. 10.3892/etm.2023.12140
- By:
- Publication type:
- Article
A randomized, double‐blind, placebo‐controlled, phase 3 study of tivantinib in Japanese patients with MET‐high hepatocellular carcinoma.
- Published in:
- Cancer Science, 2020, v. 111, n. 10, p. 3759, doi. 10.1111/cas.14582
- By:
- Publication type:
- Article